Tag: Covaxin

Bharat Biotech has been directly supplying its Covid-19 vaccine Covaxin to 18 states since May 1

Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states.

Bhubaneswar: In order to ramp up the vaccination drive in the State, Odisha government on Thursday said that people interested to inoculate themselves against Covid-19 at private hospitals can do…

Bhubaneswar: The third phase vaccination drive kicked off today in Bhubaneswar for the age group of 18 and 44. The Bhubaneswar Municipal Corporation (BMC) has initiated the exercise as decided…

Bhubaneswar: Voices of dissent have grown louder within the private medical community and political corridors in Odisha against the disparity in the prices of vaccine in Private and Government run…

New Delhi: Bharat Biotech on Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage. The Hyderabad-based vaccine major also said that it would…

New Delhi: Increasing efforts towards faster mass vaccination and virus surveillance is the key to ward off dangers posed by a triple-mutant coronavirus now present in the country, health experts…

New Delhi: Indigenously developed COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said…

New Delhi: Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug.…

New Delhi: Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while manufacture of remdesivir jabs, an anti-viral…

Hyderabad: Bharat Biotech, has successfully developed COVAXIN, India’s 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level […]

New Delhi: After Bharat Biotech’s Covaxin, another potential COVID-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got nod from the Drugs Controller General of India (DCGI) on Thursday for human clinical trials, government sources said. The approval process was fast-tracked following a recommendation by the subject expert committee on COVID-19, considering the emergency […]

New Delhi: The Indian Council of Medical Research (ICMR) said that it has partnered with Bharat Biotech to fast-track clinical trials of  India’s first indigenous COVID-19 vaccine Covaxin. ICMR Director General Balram Bhargava asserted that ICMR aims to launch the indigenous COVID-19 vaccine by August 15 after its completion of the clinical trials. In a […]

New Delhi: As India races to bring a vaccine for Covid-19 by mid-August, the government on Sunday said that it is entering the human trial stage which “marks the beginning of the end”. COVAXIN by Bharat Biotech and ZyCov-D vaccine by Zydus Cadila is India’s own efforts to bring a vaccine for this global pandemic. […]

New Delhi: As soon as the Parliamentary standing committees started to resume work after a long spell of hibernation, it was not all good news that came in front of them. Notwithstanding the ambitious target set for its market launch, the Standing Committee on Science and Technology was told on Friday that India will have […]